Total Payments
$1,894
2024 Payments
$482.11
Companies
23
Transactions
115
Medicare Patients
4,250
Medicare Billing
$272,470
Payment Breakdown by Category
Food & Beverage$1,894 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,894 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $415.40 | 31 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $218.06 | 9 | $0 (2024) |
| Novo Nordisk Inc | $139.15 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $117.88 | 7 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $111.65 | 7 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $110.04 | 5 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $106.69 | 6 | $0 (2024) |
| PFIZER INC. | $99.98 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $82.33 | 5 | $0 (2023) |
| Dexcom, Inc. | $70.56 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $482.11 | 29 | ABBVIE INC. ($167.47) |
| 2023 | $575.16 | 36 | ABBVIE INC. ($158.27) |
| 2022 | $449.42 | 26 | ABBVIE INC. ($89.66) |
| 2021 | $387.36 | 24 | Biohaven Pharmaceuticals, Inc. ($111.65) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Gastroenterology | ||||||
| 05/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Gastroenterology | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Gastroenterology | ||||||
| 04/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: VACCINES | ||||||
| 04/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: PSYCHIATRY | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Neuroscience | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
| 02/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.22 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 847 | 1,676 | $148,802 | $56,991 |
| 2022 | 12 | 552 | 862 | $113,557 | $51,256 |
| 2021 | 16 | 732 | 1,127 | $131,320 | $59,116 |
| 2020 | 30 | 2,119 | 3,763 | $277,654 | $105,108 |
Total Patients
4,250
Total Services
7,428
Medicare Billing
$272,470
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 309 | $53,148 | $23,010 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 332 | $41,500 | $16,951 | 40.8% |
| 0240U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid-19), influenza a, and influenza b) in upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 55 | 68 | $30,600 | $9,225 | 30.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 122 | 219 | $3,285 | $1,774 | 54.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $3,568 | $1,468 | 41.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 44 | 58 | $3,400 | $1,049 | 30.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $975.00 | $935.09 | 95.9% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 15 | 16 | $1,440 | $550.24 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $495.00 | $430.20 | 86.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 52 | $1,716 | $378.52 | 22.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $598.00 | $329.13 | 55.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 82 | 143 | $1,430 | $312.40 | 21.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 32 | $1,280 | $279.00 | 21.8% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 11 | $363.00 | $99.36 | 27.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 17 | 28 | $420.00 | $86.67 | 20.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 64 | $1,504 | $37.55 | 2.5% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 12 | 17 | $340.00 | $34.31 | 10.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 13 | 72 | $1,800 | $27.94 | 1.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 188 | $940.00 | $12.51 | 1.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 217 | $35,504 | $17,101 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 219 | $26,257 | $11,906 | 45.3% |
| 0240U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid-19), influenza a, and influenza b) in upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 72 | 73 | $32,850 | $10,278 | 31.3% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2022 | 17 | 17 | $7,582 | $6,789 | 89.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 18 | 18 | $1,335 | $1,224 | 91.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,486 | $1,092 | 43.9% |
About Christopher Redden, NP
Christopher Redden, NP is a Family healthcare provider based in El Reno, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1689984452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Redden, NP has received a total of $1,894 in payments from pharmaceutical and medical device companies, with $482.11 received in 2024. These payments were reported across 115 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,894).
As a Medicare-enrolled provider, Redden has provided services to 4,250 Medicare beneficiaries, totaling 7,428 services with total Medicare billing of $272,470. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location El Reno, OK
- Active Since 10/14/2010
- Last Updated 10/16/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1689984452
Products in Payments
- VRAYLAR (Drug) $415.40
- REXULTI (Drug) $206.03
- NURTEC ODT (Drug) $140.93
- JARDIANCE (Drug) $121.03
- XIFAXAN (Drug) $106.69
- Ozempic (Drug) $92.97
- ABILIFY MAINTENA (Drug) $68.95
- TOUJEO (Biological) $67.93
- Dexcom G6 Transmitter (Medical Supply) $56.75
- TRELEGY ELLIPTA (Drug) $53.44
- SHINGRIX (Biological) $46.87
- QUVIVIQ (Drug) $39.62
- PREVNAR 20 (Biological) $35.24
- ELIQUIS (Drug) $29.62
- AIRSUPRA (Drug) $27.06
- ENTRESTO (Drug) $24.90
- TRADJENTA (Drug) $20.93
- CAPLYTA (Drug) $20.05
- SPRAVATO (Drug) $19.88
- PAXLOVID (Drug) $17.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in El Reno
Lacey Hough, Aprn-Cnp, Fnp-C, APRN-CNP, FNP-C
Family — Payments: $2,010
Family $2,010
Debra Murray, Aprn-Cnp, APRN-CNP
Family — Payments: $900.24
Family $900.24
Darcy White
Family — Payments: $836.18
Family $836.18
Kristi Parish
Family — Payments: $773.54
Family $773.54
Robin Yates, Dnp, Aprn, Cnp, DNP, APRN, CNP
Family — Payments: $733.92
Family $733.92
Jana Thomas
Family — Payments: $707.20
Family $707.20